Disclaimer as of 16 March 2022
The data relating to ALIVER described on the EC website should be considered a “preliminary analysis”’ and although it is based on a fully audited and monitored Clinical Study Report, it has not been fully peer reviewed and therefore not published. Further details on the ALIVER clinical study outcomes can be found on https://yaqrit.com/news/the-aliver-consortium-announces-positive-results-from-phase-2-equivalent-trial-of-the-novel-liver-dialysis-device-dialive/ with details of the clinical study protocol on the ClinicalTrials.gov website https://www.clinicaltrials.gov/ct2/show/NCT03065699 and a copy of the Clinical Study Report is available on request from the Sponsor: Yaqrit Limited (www.yaqrit.com)
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733057
The information contained in this website reflects only the authors’ view. The European Commission is not responsible for any use that may be made of the information it contains.